Summary of MetLife (MET-PF) Q4 2025 Earnings Call

1Key Financial Results and Metrics

Q4 Adjusted Earnings: $1.6 billion, or $2.49 per share; $2.58 per share excluding notable items, a 24% increase from $2.08 a year ago.

Full Year Adjusted Earnings: $6 billion, or $8.89 per share, up approximately 10%.

Adjusted Return on Equity (ROE): 16%, within the target range of 15% to 17%.

Direct Expense Ratio: Improved to 11.7%, ahead of the 12.1% target for 2026.

Free Cash Flow: Generated $4.9 billion in 2025, part of a $25 billion five-year commitment.

Net Income: Approximately $800 million for Q4 and $3.2 billion for the full year.

2Strategic Updates and Business Highlights

New Frontier Strategy: Focused on growth, capital deployment, and operational efficiency.

Group Benefits: Added approximately $100 million in new adjusted premiums, with voluntary products growing 10% year-over-year.

Retirement Solutions: Achieved record pension risk transfer sales of over $14 billion, the highest annual total.

Acquisition of PineBridge Investments: Closed in Q4, establishing a new business segment, MetLife Investment Management (MIM), which had $742 billion in assets under management.

International Growth: Asia sales increased 18% and Latin America 12% in constant currency.

3Forward Guidance and Outlook

2026 Expectations:

Double-digit adjusted EPS growth.

Adjusted ROE to remain between 15% and 17%.

Free cash flow ratio to maintain at 65% to 75%.

Group Benefits adjusted earnings growth projected at 7% to 9%.

Retirement Solutions adjusted earnings expected between $1.6 billion and $1.8 billion.

MIM adjusted earnings anticipated between $240 million and $280 million.

4Bad News, Challenges, or Points of Concern

Disability Experience: Weaker than expected in Q4 due to higher average severity and incidents, although overall performance for the year was in line with expectations.

Variable Investment Income: Fell short of the $1.7 billion target for 2025, primarily due to lower returns from real estate and other funds.

Surrender Activity in Japan: Increased in Q4 due to currency fluctuations, although expected to stabilize in 2026.

Regulatory and Competitive Pressures: Noted potential impacts from macroeconomic volatility and competition in key markets, particularly Japan.

5Notable Q&A Insights

Group Benefits Pricing: Positive renewal season results were reported, with improved persistency and sales growth, particularly in dental and disability.

Japan Market Dynamics: Management acknowledged macroeconomic volatility affecting sales but expressed confidence in their competitive position and product offerings.

AI Impact on Employment: Management is monitoring employment trends but remains optimistic about growth in group benefits despite potential layoffs driven by AI.

Dividend Capacity: No constraints anticipated in Japan regarding dividend capacity, despite unrealized losses.

MIM Integration: Excitement about the PineBridge acquisition and its potential to enhance service offerings and client relationships. Overall, MetLife's Q4 2025 results reflect strong operational performance and strategic execution, with a positive outlook for 2026, despite some challenges in specific segments and macroeconomic factors.